Latest blog articles
-
While the story of the company is a little history of European integration in itself, it was the decision of the European Court of Justice in the case Van Gend & Loos v Nederlandse Administratie der Belastingen (1963) that gave Van Gend & Loos a place in European Union law. The case itself was...
-
How do we guarantee access to COVID-19 vaccines and therapies, and secure health-related human rights for all? We’ve heard a string of promises in the race for new vaccines and therapies.
-
It’s been almost a month since the COVID-19 pandemic has drastically changed the way we live and work. Now that we are more used to, in a manner of speaking, the extraordinary measures to curtail the rampant spread of the virus, it’s time to seriously consider, and openly discuss, this crisis’...
-
Globally the majority of health-related R&D is invested in medicines with substantial guaranteed returns, yet what is missing is extensive R&D targeted at diseases overwhelmingly prevalent in developing countries. This threatens long-term availability of medicines and treatment options for these...
-
At the start of this academic year, on the occasion of the 200th anniversary of the Kingdom of the Netherlands, I was asked to participate in a debate here in Maastricht on “borders”: the frontiers that surround us here in the southernmost part of the country to the east, west and south.
-
The KNAW just released the advisory letter on "Correct Citation" after all the commotion surrounding the case of Peter Nijkamp... This blog is only available in Dutch.